These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 15205835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.
    Debaene B, Plaud B, Dilly MP, Donati F.
    Anesthesiology; 2003 May; 98(5):1042-8. PubMed ID: 12717123
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Severe anaphylactic reactions after administration of rocuronium].
    Barthelet Y, Ryckwaert Y, Plasse C, Bonnet-Boyer MC, d'Athis F.
    Ann Fr Anesth Reanim; 1999 Oct; 18(8):896-900. PubMed ID: 10575503
    [Abstract] [Full Text] [Related]

  • 5. [Sugammadex: a new approach to muscle relaxation and its reversal].
    Duvaldestin P.
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275
    [No Abstract] [Full Text] [Related]

  • 6. Prolonged neuromuscular blockade in a horse following concomitant use of vecuronium and atracurium.
    Gurney M, Mosing M.
    Vet Anaesth Analg; 2012 Jan; 39(1):119-20. PubMed ID: 22118190
    [No Abstract] [Full Text] [Related]

  • 7. Residual paralysis following a single dose of atracurium: results from a quality assurance trial.
    Schreiber JU, Mucha E, Fuchs-Buder T.
    Eur J Anaesthesiol; 2010 Nov; 27(11):993-4. PubMed ID: 20485177
    [No Abstract] [Full Text] [Related]

  • 8. [Muscle relaxants in the ICU].
    Schneider G.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Further experiences with vercuronium in the horse.
    Martin-Flores M, Campoy L, Gleed RD.
    Vet Anaesth Analg; 2012 Mar; 39(2):218-9. PubMed ID: 22356417
    [No Abstract] [Full Text] [Related]

  • 11. The contribution of muscle relaxants to the advancement of anaesthetic practice: what is required of new compounds?
    Miller RD, von Ehrenburg W.
    Eur J Anaesthesiol Suppl; 1994 Mar; 9():1-8. PubMed ID: 7925199
    [Abstract] [Full Text] [Related]

  • 12. Atracurium associated with postoperative residual curarization.
    Kopman AF.
    Br J Anaesth; 2003 Apr; 90(4):523; author reply 523-4. PubMed ID: 12693406
    [No Abstract] [Full Text] [Related]

  • 13. Skin sensitivity to rocuronium and vecuronium: prick-tests are not intradermal test.
    Dhonneur G.
    Anesth Analg; 2005 May; 100(5):1539-1540. PubMed ID: 15845728
    [No Abstract] [Full Text] [Related]

  • 14. Vecuronium, like rocuronium, causes pain on injection.
    Ti LK, Dhara SS.
    Br J Anaesth; 1998 Sep; 81(3):487. PubMed ID: 9861154
    [No Abstract] [Full Text] [Related]

  • 15. A response to 'Masseter muscle spasm following atracurium', Reddy K & Bromley L, Anaesthesia 2004; 59: 513.
    Jenkins G.
    Anaesthesia; 2004 Jul; 59(7):733-4. PubMed ID: 15200573
    [No Abstract] [Full Text] [Related]

  • 16. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
    Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL.
    Muscle Nerve; 1994 Jun; 17(6):647-54. PubMed ID: 7910951
    [Abstract] [Full Text] [Related]

  • 17. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P, Tonetti T, Barbieri S, Frigo AC, Ori C.
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [Abstract] [Full Text] [Related]

  • 18. Atracurium versus vecuronium in asthmatic patients. A blinded, randomized comparison of adverse events.
    Caldwell JE, Lau M, Fisher DM.
    Anesthesiology; 1995 Nov; 83(5):986-91. PubMed ID: 7486185
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Impact of a quality assurance program on the use of neuromuscular monitoring and reversal of muscle relaxants].
    Motamed C, Bourgain JL.
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):297-301. PubMed ID: 19304447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.